ParreÑo, Shella .

HRN: 28-45-90  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/03/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
03/03/2026
03/03/2026
IV
1g
Ptor
Stat CS
Pending Pharmacy Acceptance 

 Indication:  ProphylaxisEmpiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: